En savoir plus
Informationen zum Autor Robin Cook, M.D., is the author of over forty books and is credited with popularizing the medical thriller with his groundbreaking and wildly successful 1977 novel, Coma . His other bestsellers include Night Shift , Viral , Genesis , Pandemic , and Charlatans . Cook divides his time between Florida, New Hampshire, and Massachusetts. Klappentext A lavishly funded! security-conscious nanotechnology institute in the foothills of the Rockies! Nano is ahead of the curve in the competitive world of molecular manufacturing! including the construction of microbivores! tiny nanorobots with the ability to gobble up viruses and bacteria. But when Pia Grazdani takes a job there! she's shocked by the secretive corporate culture. She's warned by her boss not to investigate the other work being done at the gigantic facility! nor to ask questions about the source of the seemingly endless capital that funds the institute's research. And when Pia encounters a fellow employee on a corporate jogging path suffering the effects of a seizure! she soon realizes she may have literally stumbled upon Nano's human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century—a treatment option for millions—or have they already sold out to the highest bidder? Zusammenfassung In this “excellent” (Associated Press) blend of cutting-edge science, technology, and suspense, a young woman discovers the dark underbelly of innovation, from the #1 bestselling “master of the medical thriller” ( The New York Times ). A lavishly funded, security-conscious nanotechnology institute in the foothills of the Rockies, Nano is ahead of the curve in the competitive world of molecular manufacturing, including the construction of microbivores, tiny nanorobots with the ability to gobble up viruses and bacteria. But when Pia Grazdani takes a job there, she’s shocked by the secretive corporate culture. She’s warned by her boss not to investigate the other work being done at the gigantic facility, nor to ask questions about the source of the seemingly endless capital that funds the institute’s research. And when Pia encounters a fellow employee on a corporate jogging path suffering the effects of a seizure, she soon realizes she may have literally stumbled upon Nano’s human guinea pigs. Is the tech giant on the cusp of one of the biggest medical discoveries of the twenty-first century—a treatment option for millions—or have they already sold out to the highest bidder?...
